Co-overexpression of bcl-2 and c-myc in uterine cervix carcinomas and premalignant lesions
Co-overexpression of bcl-2 and c-myc in uterine cervix carcinomas and premalignant lesions is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Co-overexpression of bcl-2 and c-myc in uterine cervix carcinomas and premalignant lesions have?
Co-overexpression of bcl-2 and c-myc in uterine cervix carcinomas and premalignant lesions has 14 citations in the OpenAlex counts ScholarIQ stores.
When was Co-overexpression of bcl-2 and c-myc in uterine cervix carcinomas and premalignant lesions published?
Co-overexpression of bcl-2 and c-myc in uterine cervix carcinomas and premalignant lesions has 2011 year in the ScholarIQ index.
What is the open-access status of Co-overexpression of bcl-2 and c-myc in uterine cervix carcinomas and premalignant lesions?
Co-overexpression of bcl-2 and c-myc in uterine cervix carcinomas and premalignant lesions has gold oa status in the ScholarIQ index.
What is the DOI of Co-overexpression of bcl-2 and c-myc in uterine cervix carcinomas and premalignant lesions?
The DOI for Co-overexpression of bcl-2 and c-myc in uterine cervix carcinomas and premalignant lesions is on the source record.
What is the PMID of Co-overexpression of bcl-2 and c-myc in uterine cervix carcinomas and premalignant lesions?
The PMID for Co-overexpression of bcl-2 and c-myc in uterine cervix carcinomas and premalignant lesions is on the source record.
What is the OpenAlex record for Co-overexpression of bcl-2 and c-myc in uterine cervix carcinomas and premalignant lesions?
The OpenAlex for Co-overexpression of bcl-2 and c-myc in uterine cervix carcinomas and premalignant lesions is on the source record.